A Randomized Phase III Trial of Hyperthermic Isolated Limb Perfusion With Melphalan, Tumor Necrosis Factor, and Interferon-Gamma in Patients With Locally Advanced Extremity Melanoma
Clinical trial NCT00001296 · COMPLETED
Trial details
- NCT number
- NCT00001296
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1992-02-01
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.